|
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes
|
Apr 2023
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
|
Apr 2021
|
Haematologica
|
aplastic anemia
|
|
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative Study
|
Apr 2021
|
BMJ Supportive & Palliative Care
|
myelodysplastic syndromes (MDS)
|
|
Eltrombopag in children with severe aplastic anemia
|
Apr 2021
|
Pediatric Blood & Cancer
|
aplastic anemia, pediatric
|
|
Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria
|
Apr 2021
|
American Journal of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia
|
Apr 2021
|
Transplantation and Cellular Therapy
|
aplastic anemia, graft versus host disease (GVHD)
|
|
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes
|
Apr 2021
|
Hematology/oncology clinics of North America
|
myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
|
|
Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
|
Mar 2021
|
Cancers
|
chronic myelomonocytic leukaemia (CMML), myelodysplastic syndromes (MDS)
|
|
Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS
|
Mar 2021
|
Bone Marrow Transplantation
|
myelodysplastic syndromes (MDS)
|
|
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|
Mar 2021
|
The New England Journal of Medicine
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
